This study aims to observe the effects of daily personalized digital reminiscence sessions, conducted with the help of a digital conversational agent, and to determine whether these sessions lead to improvements in symptoms such as apathy and depression.
The researchers therefore seek to observe whether this daily use can improve certain aspects of well-being, such as motivation, mood, sleep quality, quality of life, and engagement with the tool.
The study also aims to assess whether simple reminders delivered via the application are sufficient to encourage regular use without external assistance.
Participants will:
* Use the reminiscence app for 25 days for 10-15 minutes. * Have a primary caregiver help personalize the app by sharing family memories, other relatives may optionally contribute in a private group. * Complete brief questionnaires at the start and during follow-up routine visits (for example, apathy and depression scales, sleep, and quality of life).
Men and women over 60 years of age.
DSM-5 diagnosis: Early stage of major neurocognitive disorders or MCI (Mild Cognitive Impairment) including all underlying causes.
Have a Mini-Mental State Exam score of 21 ≤ MMSE ≤ 28.
Presence of mild or moderate depression, or presence of mild or moderate apathy, or presence of both
Patients with moderate or severe dementia (MMSE score ≤ 20) because implicit memory recall is less effective in moderate or severe stages for people with PWD.
Presence of major psychiatric disorders (e.g., schizophrenia, severe major depressive episode, bipolar disorder).
Major hearing or visual impairments.
History of premorbid intellectual disability.
KompanionCare SAS
Lead sponsor
Clinical Research Units Hungary
Collaborator